Literature DB >> 2934204

Protective effect of nicotinamide against nephropathy in diabetic rats.

G Wahlberg, L A Carlson, J Wasserman, A Ljungqvist.   

Abstract

Nicotinamide was given for 6 months to rats with streptozotocin induced diabetes. Presence of glomerular depositions (mesangial distribution) of IgG was evaluated with immunofluorescence technique. The immunofluorescence staining of the nicotinamide-treated diabetic rats was significantly less pronounced than that of the untreated diabetic rats. Normal age matched controls showed no such staining. The results indicate that nicotinamide retarded the development of the diabetic nephropathy. The findings might be explained by a normalizing effect of nicotinamide on a disturbed tryptophan and/or nicotinamide adenine dinucleotide metabolism. A metabolic hypothesis is formulated, which is consistent with the "glucose overutilization" theory.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934204

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  4 in total

Review 1.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

2.  Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.

Authors:  G Pugliese; R G Tilton; A Speedy; K Chang; E Santarelli; M A Province; D Eades; W R Sherman; J R Williamson
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

Review 3.  Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.

Authors:  Pál Pacher; Csaba Szabó
Journal:  Antioxid Redox Signal       Date:  2005 Nov-Dec       Impact factor: 8.401

Review 4.  Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.

Authors:  Seon Beom Song; Jin Sung Park; Gu June Chung; In Hye Lee; Eun Seong Hwang
Journal:  Metabolomics       Date:  2019-10-05       Impact factor: 4.290

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.